SPR Therapeutics
Cleveland-based provider of peripheral nerve stimulation therapies for chronic pain management; raised ~$172M from VCs before $650M acquisition by Medtronic.
- The other midterm winners
- AI Stocks Lead Market Meltdown
- Anthropic's Model Continues Hacking Attack Even After Told It's Causing Harm
- Thrive Capital's Bet on Neuralink, OpenAI & the Future of Medicine
- 🔥World's Hottest Startups in August 2026
- EU Regulators Fine Google $1B
- AI's true cost
- U.S. Aims Anthropic's Mythos at Government Code
“secured a $133 million Series B led by Advent Life Sciences and British Business Bank”
Source→“raised a $133 million Series B round co-led by Advent Life Sciences and British Business Bank.”
Source→“raised $133m in Series B funding. Advent Life Sciences and British Business Bank led.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.